Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials
Date
2016
Authors
Yasar, Sevil
Schuchman, Mattan
Peters, Jean
Anstey, Kaarin
Carlson, Michelle
Peters, Ruth
Journal Title
Journal ISSN
Volume Title
Publisher
Current Science Inc.
Abstract
Purpose of review
There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer’s disease; however, associations between antihypertensive medications (AHMs) and dementia risk are less consistent. An increased interest in AHM has resulted in expanding publications; however, none of the recent reviews are comprehensive. Our extensive review includes 15 observational and randomized controlled trials (RCTs) published over the last 5 years, assessing the relationship between AHM and cognitive impairment.
Recent findings
All classes of AHM showed similar result patterns in human studies with the majority of study results reporting point estimates below one and only a small number of studies (N = 15) reporting statistically significant results in favor of a specific class.
Summary
Only a small number of studies reported statistically significant results in favor of a specific class of AHM. Methodological limitations of the studies prevent definitive conclusions. Further work is now needed to evaluate the class of AHM and cognitive outcomes in future RCTs, with a particular focus on the drugs with the promising results in both animals and human observational studies.
Description
Keywords
Antihypertensive medication, Cognitive decline, Dementia, Alzheimer’sdisease
Citation
Collections
Source
Current Hypertension Reports
Type
Journal article
Book Title
Entity type
Access Statement
Open Access
License Rights
Creative Commons Attribution licence
Restricted until
Downloads
File
Description